+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • October 2022
  • 63 Pages
  • Global
From
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape - Product Thumbnail Image

Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape

  • Report
  • October 2022
  • 60 Pages
  • Global
From
Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 66 Pages
  • Global
From
Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 74 Pages
  • Global
From
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 176 Pages
  • Global
From
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 76 Pages
  • Global
From
Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2022
  • 59 Pages
  • Global
From
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 68 Pages
  • Global
From
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update - Product Thumbnail Image

Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

  • Report
  • March 2022
  • 58 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Hyperinsulinemia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hyperinsulinemia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 93 Pages
  • Global
From
Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 98 Pages
  • Global
From
Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 283 Pages
  • Global
From
Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Overactive Bladder - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 130 Pages
  • Global
From
Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 108 Pages
  • Global
From
Severe Sepsis and Septic Shock - Epidemiology Forecast to 2030 - Product Thumbnail Image

Severe Sepsis and Septic Shock - Epidemiology Forecast to 2030

  • Report
  • August 2021
  • 52 Pages
  • Global
From
Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029

  • Report
  • November 2020
  • 225 Pages
  • Global
From
Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • Report
  • October 2020
  • 133 Pages
  • Global
From
Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026

  • Report
  • May 2018
  • 127 Pages
  • Global
From
South Korea Anti-Rheumatic Drug Market - Strategic Insights and Forecasts (2026-2031) - Product Thumbnail Image

South Korea Anti-Rheumatic Drug Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • May 2026
  • 75 Pages
  • South Korea
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more